Texas Abortion Pill Ruling Sparks Legal Battle Over FDA Authority.

Two federal judges issued conflicting rulings on the safety and effectiveness of mifepristone, a key abortion drug, putting the FDA in an unprecedented legal bind. The ruling in Texas, which blocks the agency's approval of mifepristone, could permanently undermine the FDA's authority to approve and regulate medications. Legal scholars warn that this could lead to a legal showdown before a conservative Supreme Court that overturned the constitutional right to an abortion last June. The FDA said it would appeal the decision.